Four CNS drugs to come under Schedule H1 controls amid abuse concerns
Four widely used Central Nervous System medications, including Zopiclone and Gabapentin, have been placed under Schedule H1 controls amid concerns over over-the-counter availability and off-label intoxication. Chemists will have to follow stricter prescription, record-keeping and warning-label requirements for these drugs.
